» Articles » PMID: 25803302

Analysis and Prediction of the Critical Regions of Antimicrobial Peptides Based on Conditional Random Fields

Overview
Journal PLoS One
Date 2015 Mar 25
PMID 25803302
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial peptides (AMPs) are potent drug candidates against microbes such as bacteria, fungi, parasites, and viruses. The size of AMPs ranges from less than ten to hundreds of amino acids. Often only a few amino acids or the critical regions of antimicrobial proteins matter the functionality. Accurately predicting the AMP critical regions could benefit the experimental designs. However, no extensive analyses have been done specifically on the AMP critical regions and computational modeling on them is either non-existent or settled to other problems. With a focus on the AMP critical regions, we thus develop a computational model AMPcore by introducing a state-of-the-art machine learning method, conditional random fields. We generate a comprehensive dataset of 798 AMPs cores and a low similarity dataset of 510 representative AMP cores. AMPcore could reach a maximal accuracy of 90% and 0.79 Matthew's correlation coefficient on the comprehensive dataset and a maximal accuracy of 83% and 0.66 MCC on the low similarity dataset. Our analyses of AMP cores follow what we know about AMPs: High in glycine and lysine, but low in aspartic acid, glutamic acid, and methionine; the abundance of α-helical structures; the dominance of positive net charges; the peculiarity of amphipathicity. Two amphipathic sequence motifs within the AMP cores, an amphipathic α-helix and an amphipathic π-helix, are revealed. In addition, a short sequence motif at the N-terminal boundary of AMP cores is reported for the first time: arginine at the P(-1) coupling with glycine at the P1 of AMP cores occurs the most, which might link to microbial cell adhesion.

Citing Articles

AMPActiPred: A three-stage framework for predicting antibacterial peptides and activity levels with deep forest.

Yao L, Guan J, Xie P, Chung C, Deng J, Huang Y Protein Sci. 2024; 33(6):e5006.

PMID: 38723168 PMC: 11081525. DOI: 10.1002/pro.5006.


Peptidome Profiling of Urine and Assessment of Its Antimicrobial Activity against Mastitis-Causing Pathogens.

Kumar R, Tyagi N, Nagpal A, Kaushik J, Mohanty A, Kumar S Antibiotics (Basel). 2024; 13(4).

PMID: 38666975 PMC: 11047597. DOI: 10.3390/antibiotics13040299.


AntiBP3: A Method for Predicting Antibacterial Peptides against Gram-Positive/Negative/Variable Bacteria.

Bajiya N, Choudhury S, Dhall A, Raghava G Antibiotics (Basel). 2024; 13(2).

PMID: 38391554 PMC: 10885866. DOI: 10.3390/antibiotics13020168.


Recent Progress in the Discovery and Design of Antimicrobial Peptides Using Traditional Machine Learning and Deep Learning.

Yan J, Cai J, Zhang B, Wang Y, Wong D, Siu S Antibiotics (Basel). 2022; 11(10).

PMID: 36290108 PMC: 9598685. DOI: 10.3390/antibiotics11101451.


Identification and Functional Characterization of Peptides With Antimicrobial Activity From the Syphilis Spirochete, .

Houston S, Schovanek E, Conway K, Mustafa S, Gomez A, Ramaswamy R Front Microbiol. 2022; 13:888525.

PMID: 35722306 PMC: 9200625. DOI: 10.3389/fmicb.2022.888525.


References
1.
Sorensen O, Follin P, Johnsen A, Calafat J, Tjabringa G, Hiemstra P . Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001; 97(12):3951-9. DOI: 10.1182/blood.v97.12.3951. View

2.
Punta M, Coggill P, Eberhardt R, Mistry J, Tate J, Boursnell C . The Pfam protein families database. Nucleic Acids Res. 2011; 40(Database issue):D290-301. PMC: 3245129. DOI: 10.1093/nar/gkr1065. View

3.
Conchillo-Sole O, de Groot N, Aviles F, Vendrell J, Daura X, Ventura S . AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics. 2007; 8:65. PMC: 1828741. DOI: 10.1186/1471-2105-8-65. View

4.
Zasloff M . Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 1987; 84(15):5449-53. PMC: 298875. DOI: 10.1073/pnas.84.15.5449. View

5.
DUBOS R . STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS : I. PREPARATION OF THE AGENT. ITS ACTIVITY IN VITRO. J Exp Med. 2009; 70(1):1-10. PMC: 2133784. DOI: 10.1084/jem.70.1.1. View